News
FAT jabs do often sound like a magical quick fix to overeating and demanding hunger pangs. But the drugs can leave some ...
12h
ABP News on MSNBeyond The Hype — What India Must Know About Weight-Loss DrugsWeight-loss injections like semaglutide are trending in India, but are they safe? Know the science, risks, and why expert ...
Miracle’ drugs used for weight-loss like Semaglutide and Tirzepatide—better known by their brand names Ozempic and ...
Eli Lilly & Company (NYSE:LLY) ranks among the best low volatility stocks to buy according to analysts. On July 11, ...
8h
News-Medical.Net on MSNWhich GLP-1 meds have the most side effects? Study of 60,000 Facebook posts gives answersResearchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...
CBL-514, Caliway's first-in-class lipolysis drug candidate, has been granted clearance from the U.S. FDA to proceed with SUPREME-01, a global, ...
Explore more
Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...
Pharmacists warn that the escalating demand for weight loss drugs may soon exceed supply, potentially driving consumers to ...
A MUM who lost a staggering nine stone on a weight-loss jab says her hair started falling out in clumps, until she found an ...
Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...
4h
Vietnam Investment Review on MSNAscletis Begins Dosing in U S Phase IIa Study for Monthly GLP 1R Obesity DrugAscletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today that the first participants with obesity or overweight with at least one weight-related comorbidity have been dosed in its U.S. 12-week ...
Eli Lilly and Company (NYSE:LLY) is experiencing a strong analyst sentiment amid its expanding role in cutting-edge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results